AI assistant
Sending…
Pacira BioSciences, Inc. — Director's Dealing 2013
May 18, 2013
32125_dirs_2013-05-17_7b2da306-c263-4b45-9217-7a9c018be45c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2013-05-15
Reporting Person: HASTINGS PAUL J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-15 | Common Stock | P | 853 | $29.30 | Acquired | 853 | Direct |
More from Pacira BioSciences, Inc.
Proxy Solicitation & Information Statement
2026
May 26
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 19
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 12
Interim / Quarterly Report
2026
Apr 30
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19